Savara Inc SVRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
2/9
Piotroski F — financial health
-1.13
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | — | -$118.8M | — | -$101.1M | $203.1M |
| 2024 | — | -$95.9M | — | -$89.1M | -$750,000 |
| 2023 | — | -$54.7M | — | -$51.4M | -$271,000 |
| 2022 | — | -$38.1M | — | -$34.6M | -$605,000 |
| 2021 | — | -$43.0M | — | -$40.1M | $144.5M |
| 2020 | $257,000 | -$49.6M | — | -$39.9M | $64.4M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Tax withheld | 21,682 | $5.50 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Option exercise | 129,350 | $1.23 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Tax withheld | 28,928 | $5.50 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Option exercise | 56,937 | $1.11 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Tax withheld | 11,491 | $5.50 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Option exercise | 218,750 | $1.51 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Tax withheld | 60,057 | $5.50 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Option exercise | 75,000 | $1.59 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.13 (distress)
- Working capital / assets 0.873
- Retained earnings / assets -2.399
- EBIT / assets -0.487
- Equity / liabilities 4.038
Source: SEC EDGAR filings · CIK 0001160308 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.